Altered kynurenine metabolism correlates with infarct volume in stroke - PubMed (original) (raw)
Altered kynurenine metabolism correlates with infarct volume in stroke
L G Darlington et al. Eur J Neurosci. 2007 Oct.
Abstract
Inflammation and oxidative stress are involved in brain damage following stroke, and tryptophan oxidation along the kynurenine pathway contributes to the modulation of oxidative stress partly via the glutamate receptor agonist quinolinic acid and antagonist kynurenic acid, and via redox-active compounds such as 3-hydroxyanthranilic acid. We have confirmed that following a stroke, patients show early elevations of plasma neopterin, S100B and peroxidation markers, the latter two correlating with infarct volume assessed from computed tomography (CT) scans, and being consistent with a rapid inflammatory response. We now report that the kynurenine pathway of tryptophan metabolism was also activated, with an increased kynurenine : tryptophan ratio, but with a highly significant decrease in the ratio of 3-hydroxyanthranilic acid : anthranilic acid, which was strongly correlated with infarct volume. Levels of kynurenic acid were significantly raised in patients who died within 21 days compared with those who survived. The results suggest that increased tryptophan catabolism is initiated before or immediately after a stroke, and is related to the inflammatory response and oxidative stress, with a major change in 3-hydroxyanthranilic acid levels. Together with previous evidence that inhibiting the kynurenine pathway reduces brain damage in animal models of stroke and cerebral inflammation, and that increased kynurenine metabolism directly promotes oxidative stress, it is proposed that oxidative tryptophan metabolism may contribute to the oxidative stress and brain damage following stroke. Some form of anti-inflammatory intervention between the rise of S100B and the activation of microglia, including inhibition of the kynurenine pathway, may be valuable in modifying patient morbidity and mortality.
Similar articles
- Tryptophan metabolism and oxidative stress in patients with chronic brain injury.
Mackay GM, Forrest CM, Stoy N, Christofides J, Egerton M, Stone TW, Darlington LG. Mackay GM, et al. Eur J Neurol. 2006 Jan;13(1):30-42. doi: 10.1111/j.1468-1331.2006.01220.x. Eur J Neurol. 2006. PMID: 16420391 - Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery.
Forrest CM, Mackay GM, Oxford L, Millar K, Darlington LG, Higgins MJ, Stone TW. Forrest CM, et al. J Neurochem. 2011 Oct;119(1):136-52. doi: 10.1111/j.1471-4159.2011.07414.x. Epub 2011 Sep 1. J Neurochem. 2011. PMID: 21819405 - Tryptophan metabolism and oxidative stress in patients with Huntington's disease.
Stoy N, Mackay GM, Forrest CM, Christofides J, Egerton M, Stone TW, Darlington LG. Stoy N, et al. J Neurochem. 2005 May;93(3):611-23. doi: 10.1111/j.1471-4159.2005.03070.x. J Neurochem. 2005. PMID: 15836620 - Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K, Robotka H, Toldi J, Vécsei L. Sas K, et al. J Neurol Sci. 2007 Jun 15;257(1-2):221-39. doi: 10.1016/j.jns.2007.01.033. Epub 2007 Apr 25. J Neurol Sci. 2007. PMID: 17462670 Review.
Cited by
- Variation of Genes Encoding Tryptophan Catabolites Pathway Enzymes in Stroke.
Wigner P, Saluk-Bijak J, Synowiec E, Miller E, Sliwinski T, Cichon N, Bijak M. Wigner P, et al. J Clin Med. 2019 Dec 3;8(12):2133. doi: 10.3390/jcm8122133. J Clin Med. 2019. PMID: 31817010 Free PMC article. - Tryptophan Metabolism, Inflammation, and Oxidative Stress in Patients with Neurovascular Disease.
Hajsl M, Hlavackova A, Broulikova K, Sramek M, Maly M, Dyr JE, Suttnar J. Hajsl M, et al. Metabolites. 2020 May 19;10(5):208. doi: 10.3390/metabo10050208. Metabolites. 2020. PMID: 32438592 Free PMC article. - Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis.
Gaetani L, Boscaro F, Pieraccini G, Calabresi P, Romani L, Di Filippo M, Zelante T. Gaetani L, et al. Front Immunol. 2020 Feb 18;11:157. doi: 10.3389/fimmu.2020.00157. eCollection 2020. Front Immunol. 2020. PMID: 32132996 Free PMC article. - Kynurenines and other novel therapeutic strategies in the treatment of dementia.
Majláth Z, Tajti J, Vécsei L. Majláth Z, et al. Ther Adv Neurol Disord. 2013 Nov;6(6):386-97. doi: 10.1177/1756285613494989. Ther Adv Neurol Disord. 2013. PMID: 24228074 Free PMC article. - Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.
Chouraki V, Preis SR, Yang Q, Beiser A, Li S, Larson MG, Weinstein G, Wang TJ, Gerszten RE, Vasan RS, Seshadri S. Chouraki V, et al. Alzheimers Dement. 2017 Dec;13(12):1327-1336. doi: 10.1016/j.jalz.2017.04.009. Epub 2017 Jun 8. Alzheimers Dement. 2017. PMID: 28602601 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous